- Home
- BBD vs WST Comparison
BBD vs WST Comparison
Compare BBD & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBD
- WST
- Stock Information
- Founded
- BBD 1943
- WST 1923
- Country
- BBD Brazil
- WST United States
- Employees
- BBD N/A
- WST N/A
- Industry
- BBD Major Banks
- WST Medical/Dental Instruments
- Sector
- BBD Finance
- WST Health Care
- Exchange
- BBD Nasdaq
- WST Nasdaq
- Market Cap
- BBD 30.6B
- WST 18.9B
- IPO Year
- BBD N/A
- WST N/A
- Fundamental
- Price
- BBD $3.19
- WST $258.04
- Analyst Decision
- BBD Strong Buy
- WST Buy
- Analyst Count
- BBD 4
- WST 7
- Target Price
- BBD $2.55
- WST $332.50
- AVG Volume (30 Days)
- BBD 32.9M
- WST 575.5K
- Earning Date
- BBD 10-30-2025
- WST 10-23-2025
- Dividend Yield
- BBD 4.96%
- WST 0.35%
- EPS Growth
- BBD 58.81
- WST N/A
- EPS
- BBD 0.36
- WST 6.68
- Revenue
- BBD $16,114,445,927.00
- WST $2,960,200,000.00
- Revenue This Year
- BBD $72.65
- WST $6.28
- Revenue Next Year
- BBD $8.90
- WST $6.02
- P/E Ratio
- BBD $8.13
- WST $37.92
- Revenue Growth
- BBD 27.09
- WST 2.90
- 52 Week Low
- BBD $1.84
- WST $187.43
- 52 Week High
- BBD $3.24
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- BBD 63.91
- WST 59.88
- Support Level
- BBD $3.11
- WST $253.38
- Resistance Level
- BBD $3.20
- WST $264.06
- Average True Range (ATR)
- BBD 0.07
- WST 5.62
- MACD
- BBD 0.01
- WST 0.67
- Stochastic Oscillator
- BBD 82.76
- WST 73.15
About BBD Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.